News | Interventional Radiology | December 12, 2018

Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018

Company highlights injection management tools, new product launches and joint RSNA scholarship grant awardee

Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018

December 12, 2018 — Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors, disposables, digital solutions and services at the 2018 annual meeting of the Radiological Society of North America (RSNA), Nov. 25-30 in Chicago.

At Guerbet's booth, interactive workstations provided live demonstrations of novel clinical tools for diagnostic and interventional imaging, including:

  • Contrast & Care, a next-level contrast media injection management solution that enables imaging centers to collect, archive, examine and share data directly with Guerbet's injectors to help radiologists with patient care; and
  • Imalogix, a new self-learning neural network that enables organizations to understand and benchmark best practices from the mass learnings in real time across a network of providers to drive continuous improvement.

Guerbet also highlighted additional key milestones achieved this year, including:

  • Product launches:
  • Partnership:
    • Joined forces with the Association for Medical Imaging Management (AHRA) "Defining Our Future" campaign, an initiative to support the education, development, and empowerment of new and future medical imaging professionals.

Guerbet's macrocyclic ionic contrast agent Dotarem (gadoterate meglumine) remains the first and only macrocyclic and ionic GBCA molecule approved by the U.S. Food and Drug Administration (FDA), according to the company, recently surpassing its 85 millionth dose worldwide. This year, Guerbet is celebrating the five-year anniversary of Dotarem's U.S. launch in March 2013 (and its first pediatric and adult injections in July and September 2013 respectively), all on the heels of Dotarem's "under age 2" pediatric approval last September.

Guerbet also celebrated the granting of the Guerbet/RSNA Research Scholar Grant, by the RSNA Research & Education Foundation to Avener Meoded, M.D., of Johns Hopkins University.  The $150,000 two-year grant will help fund Meoded's research using a comprehensive "omics" approach in the study of brain neuroplasticity in pediatric arterial ischemic stroke.

For more information: www.guerbet.com

Related Content

FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
Fluke Biomedical Introduces RaySafe 452 Survey Meter
Technology | Radiation Dose Management | July 11, 2019
Radiation measurement often requires different devices for varying applications, adding to the cost and complexity of...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Mednax National Cardiac Centers of Excellence Program Highlighted at SCCT 2019
News | CT Angiography (CTA) | July 11, 2019
Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...